MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong
· Delayed Price · Currency is HKD 3.500
+0.040 (1.16%)
Mar 10, 2026, 1:10 PM HKT
HKG:2160 Revenue
MicroPort CardioFlow Medtech had revenue of 229.10M CNY in the half year ending June 30, 2025, with 29.85% growth. This brings the company's revenue in the last twelve months to 367.53M, down -4.02% year-over-year. In the year 2024, MicroPort CardioFlow Medtech had annual revenue of 361.57M with 7.54% growth.
Revenue (ttm)
367.53M CNY
Revenue Growth
-4.02%
P/S Ratio
10.94
Revenue / Employee
881.37K CNY
Employees
417
Market Cap
4.41B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Peijia Medical | 731.61M |
| Acotec Scientific Holdings | 649.64M |
| LEPU ScienTech Medical Technology (Shanghai) | 605.14M |
| MicroTech Medical (Hangzhou) | 482.95M |
| MicroPort NeuroScientific | 807.00M |
| AK Medical Holdings | 1.52B |
| China Isotope & Radiation | 8.35B |
| Zylox-Tonbridge Medical Technology | 984.51M |